Trial · NCT02243306
Results by group293
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 293
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK1278863; Day 1; n=1, 7 | 184.9863 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK1278863; Day 1; n=1, 7 | 138.6511 | Geometric Coefficient of Variation 93.5 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK1278863; Day 14; n=1, 4 | 162.9366 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK1278863; Day 14; n=1, 4 | 131.2826 | Geometric Coefficient of Variation 78.8 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2391220; Day 1; n=1, 7 | 245.8999 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2391220; Day 1; n=1, 7 | 147.8039 | Geometric Coefficient of Variation 47.7 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2391220; Day 14; n=1, 4 | 258.1199 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2391220; Day 14; n=1, 4 | 162.0324 | Geometric Coefficient of Variation 50.7 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2487818; Day 1; n=1, 7 | 116.2608 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2487818; Day 1; n=1, 7 | 67.4130 | Geometric Coefficient of Variation 39.1 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2487818; Day 14; n=1, 4 | 114.1857 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2487818; Day 14; n=1, 4 | 59.6501 | Geometric Coefficient of Variation 51.5 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2506102; Day 1; n=1,6 | 59.0619 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2506102; Day 1; n=1,6 | 44.8180 | Geometric Coefficient of Variation 37.8 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2506102; Day 14; n=1, 4 | 82.9794 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2506102; Day 14; n=1, 4 | 65.2188 | Geometric Coefficient of Variation 63.0 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2531398; Day 1; n=1, 7 | 97.0339 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2531398; Day 1; n=1, 7 | 63.0979 | Geometric Coefficient of Variation 45.5 | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing CAPD | GSK2531398; Day 14; n=1, 4 | 97.6587 | Geometric Coefficient of Variation NA | Hour into nanograms per milliliter |
| Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau]) of GSK1278863 and Its Metabolites | Participants Undergoing APD | GSK2531398; Day 14; n=1, 4 | 65.9664 | Geometric Coefficient of Variation 53.5 | Hour into nanograms per milliliter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02243306/results